SPDR S&P Biotech (XBI)

Add to Watchlists
Create an Alert
56.85 +0.63  +1.12% NYSE Arca May 27, 16:09 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

Expense Ratio (6-30-15) 0.35%
Assets Under Management (5-26-16) 1.856B
30-Day Average Volume (5-26-16) 6.492M
Net Asset Value (5-26-16) 56.16
Discount or Premium to NAV (5-26-16) 0.11%
Turnover Ratio (6-30-15) 78.00%

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.12% 0.12% 0.00%
Stock 99.88% 99.88% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of May 25, 2016

XBI Net Fund Flows

1M -169.73M
3M 168.51M
6M -76.53M
YTD 84.54M
1Y 277.24M
3Y 769.60M
5Y 770.32M
10Y 1.312B
As of April 30, 2016

XBI Net Share Class Flows

1M -169.73M
3M 168.51M
6M -76.53M
YTD 84.54M
1Y 277.24M
3Y 769.60M
5Y 770.32M
10Y 1.312B
As of April 30, 2016

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of May 25, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of May 25, 2016

XBI Stock Market Capitalization

Giant 7.28%
Large 9.50%
Medium 21.66%
Small 36.62%
Micro 24.78%
As of May 25, 2016
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
ACAD ACADIA Pharmaceuticals Inc 3.08% 35.61 +2.03%
MDVN Medivation Inc 2.78% 60.63 +0.53%
ANAC Anacor Pharmaceuticals Inc 2.75% 99.46 -0.61%
ALKS Alkermes PLC 2.33% 46.13 +4.15%
NBIX Neurocrine Biosciences Inc 2.31% 46.19 +0.79%
SGEN Seattle Genetics Inc 2.13% 40.25 +1.67%
ICPT Intercept Pharmaceuticals Inc 2.12% 141.93 +3.05%
LGND Ligand Pharmaceuticals Inc 2.12% 122.83 +0.71%
NVAX Novavax Inc 2.09% 5.86 +4.27%
INCY Incyte Corp 2.07% 84.53 +3.36%
As of May 25, 2016
Advertisement

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
John Tucker 10.09 yrs
Karl Schneider 1.33 yrs
Michael Feehily 4.34 yrs

XBI Risk Info

Beta 1.387
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.6368
Historical Sortino (All) 0.8505
30-Day Rolling Volatility 34.16%
Daily Value at Risk (VaR) 1% (All) 4.98%
Monthly Value at Risk (VaR) 1% (All) 21.71%

XBI Fundamentals

Dividend Yield TTM (5-27-16) 0.71%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.495
Weighted Average Price to Book Ratio 4.672
Weighted Median ROE -9.67%
Weighted Median ROA -14.57%
Forecasted Dividend Yield 0.14%
Forecasted PE Ratio 23.61
Forecasted Price to Sales Ratio 6.218
Forecasted Price to Book Ratio 2.381
Number of Holdings 89
As of May 25, 2016

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 23.12%
Forecasted Book Value Growth 29.23%
Forecasted Cash Flow Growth 33.15%
Forecasted Earnings Growth 23.08%
Forecasted Revenue Growth 20.03%
As of May 25, 2016

XBI Performance

  Returns Total Returns
1M 0.30% 0.30%
3M 13.81% 13.94%
6M -22.40% -22.14%
1Y -27.62% -27.20%
3Y 53.04% 56.20%
5Y 127.5% 132.8%
As of May 26, 2016

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2015
Last Prospectus Date 2/3/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.